Literature DB >> 28199527

Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant Mechanisms.

Hassan Melhem1, Marianne R Spalinger1, Jesus Cosin-Roger1, Kirstin Atrott1, Silvia Lang1, Kacper A Wojtal1, Stephan R Vavricka2,3,4, Gerhard Rogler2,3, Isabelle Frey-Wagner2,3.   

Abstract

BACKGROUND AND AIMS: An imbalance between cellular antioxidant defence system[s] and reactive oxygen species [ROS]-driven oxidative stress has been implicated in the pathogenesis of inflammatory bowel disease. Peroxiredoxin [PRDX] 6 contributes to an appropriate redox balance by clearing ROS and reducing peroxidized membrane phospholipids. We here studied the role of PRDX6 in acute and chronic dextran sodium sulphate [DSS]-induced colitis.
METHODS: To investigate the impact of PRDX6 on intestinal inflammation, we used wild type [WT], Prdx6 knock-out mice [Prdx6-/-] and transgenic mice [Prdx6tg/tg], overexpressing Prdx6. Acute and chronic colitis was induced by DSS in WT, Prdx6-/- and Prdx6tg/tg mice. Colitis was evaluated by endoscopy, colon length, histopathological assessment and myeloperoxidase [MPO] activity. Changes in mRNA and protein expression of pro-inflammatory cytokines and antioxidant enzymes were evaluated by real-time quantitative polymerase chain reaction [RT-qPCR] and western blot. Total glutathione [GSH] levels in colon samples were determined.
RESULTS: Prdx6-/- mice exposed to acute and chronic DSS showed a significant decrease in the clinical parameters and in colonic expression of pro-inflammatory cytokines compared with WT mice. mRNA expression of antioxidant enzymes in colon samples was significantly increased in Prdx6-/- compared with WT mice exposed to acute and chronic DSS. In addition, total GSH levels were increased in Prdx6-/- mice treated with DSS in comparison with WT. Overexpression of Prdx6 did not significantly influence acute and chronic colitis.
CONCLUSIONS: Our data indicate that a lack of the antioxidant enzyme PRDX6 protects against the development of acute and chronic experimental colitis and is associated with increased expression and function of other antioxidant enzymes, suggesting effective compensatory mechanisms.
Copyright © 2017 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  IBD; Prdx6; ROS; antioxidant enzymes; colitis

Mesh:

Substances:

Year:  2017        PMID: 28199527     DOI: 10.1093/ecco-jcc/jjx016

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  7 in total

Review 1.  The Roles of Peroxiredoxin 6 in Brain Diseases.

Authors:  Jiangfeng Liao; Yusi Zhang; Xiaochun Chen; Jing Zhang
Journal:  Mol Neurobiol       Date:  2021-05-19       Impact factor: 5.590

Review 2.  Cellular Stress Responses and Gut Microbiota in Inflammatory Bowel Disease.

Authors:  Siyan Stewart Cao
Journal:  Gastroenterol Res Pract       Date:  2018-06-20       Impact factor: 2.260

3.  Lack of the peroxiredoxin 6 gene causes impaired spatial memory and abnormal synaptic plasticity.

Authors:  Sarayut Phasuk; Sureka Jasmin; Tanita Pairojana; Hsueh-Kai Chang; Kai-Chi Liang; Ingrid Y Liu
Journal:  Mol Brain       Date:  2021-04-19       Impact factor: 4.041

4.  Epithelial GPR35 protects from Citrobacter rodentium infection by preserving goblet cells and mucosal barrier integrity.

Authors:  Hassan Melhem; Berna Kaya; Tanay Kaymak; Philipp Wuggenig; Emilio Flint; Julien Roux; Koen C Oost; Claudia Cavelti-Weder; Maria L Balmer; Jean-Claude Walser; Rodrigo A Morales; Christian U Riedel; Prisca Liberali; Eduardo J Villablanca; Jan Hendrik Niess
Journal:  Mucosal Immunol       Date:  2022-03-09       Impact factor: 8.701

Review 5.  Essential Roles of Peroxiredoxin IV in Inflammation and Cancer.

Authors:  Pratik Thapa; Na Ding; Yanning Hao; Aziza Alshahrani; Hong Jiang; Qiou Wei
Journal:  Molecules       Date:  2022-10-02       Impact factor: 4.927

Review 6.  Knockout Mouse Models for Peroxiredoxins.

Authors:  Young Jae Lee
Journal:  Antioxidants (Basel)       Date:  2020-02-22

7.  FA-97, a New Synthetic Caffeic Acid Phenethyl Ester Derivative, Ameliorates DSS-Induced Colitis Against Oxidative Stress by Activating Nrf2/HO-1 Pathway.

Authors:  Yu Mei; Zihao Wang; Yifan Zhang; Ting Wan; Jincheng Xue; Wei He; Yi Luo; Yijun Xu; Xue Bai; Qi Wang; Yujie Huang
Journal:  Front Immunol       Date:  2020-01-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.